http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1800916_PMID

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID252106898_AID1800916_PMID_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID252106898_AID1800916_PMID_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID252106898_AID1800916_PMID_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID252106898_AID1800916_PMID_VALUE2
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06401
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP03372
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10275
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04150
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title Inhibition Assay from US Patent US8957057: \"Use of azaphilone compounds for the modulation of the activity of a nuclear hormone receptor\"
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID252106898
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1800916

Total number of triples: 13.